Neumora Therapeutics News

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pinto Joshua

Jun 28 21:02 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ho Maykin

Jun 14 16:28 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Piacquad David

Jun 14 16:24 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Halawa Alaa

Jun 14 16:20 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K

Jun 14 16:18 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Burow Kristina

Jun 14 16:16 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh

Apr 24 17:05 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Pinto Joshua

Feb 16 16:27 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BERNS PAUL L

Feb 16 16:25 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aurora Daljit Singh

Feb 16 16:23 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Suh Carol Y.

Feb 16 16:22 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lenz Robert A.

Feb 16 16:20 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Milligan Michael Lee

Feb 16 16:20 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gosebruch Henry O

Feb 16 16:17 ET

Neumora Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Paul L Berns(5.2%)

Feb 14 16:25 ET

Neumora Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-SoftBank Group Corp.(5.0%),SB Global Advisers Limited(5.0%), etc.

Feb 13 18:09 ET

Neumora Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund VII, L.P.(20.9%),ARCH Venture Fund VIII Overage, L.P.(20.9%), etc.

Dec 15, 2023 17:06 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Partners XII, LLC

Dec 12, 2023 19:53 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Partners X, LLC

Dec 12, 2023 19:52 ET

Neumora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Burow Kristina

Dec 12, 2023 19:52 ET